BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up - Report - MDSpire

BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

  • By

  • Naoki Oike

  • Reiko Imai

  • Akira Ogose

  • Takashi Ariizumi

  • Yudai Murayama

  • Tomohiro Miyazaki

  • Kazunaga Kimura

  • Hajime Umezu

  • Hiroyuki Kawashima

  • June 10, 2026

  • 0 min

Share

Management of BCOR-CCNB3 Fusion-Positive Sarcoma with Chemotherapy and CIRT

Overview

{'additional_info': 'Specify follow-up assessments conducted during the 12 years.'}

Background

{'additional_info': 'Discuss treatment challenges specific to BCS.'}

Data Highlights

{'format': 'Remove HTML tags and summarize any relevant numerical data.'}

Key Findings

{'clarification': 'Ensure findings are supported by case details and include imaging results.'}

Clinical Implications

{'expansion': 'Discuss implications of CIRT in existing treatment protocols.'}

Conclusion

{'suggestion': 'Identify specific areas for future research.'}

Related Resources & Content

  1. Progress in Multidisciplinary Surgical Strategies for Primary Spinal Sarcomas: Findings from a Retrospective Case Series on Patient Outcomes and Survival Rates
  2. Emergence of Neurometastatic Merkel Cell Carcinoma: A Case Series and Review of Existing Literature
  3. Impact of Integrating Targeted Therapies or Chemotherapy with Stereotactic Radiosurgery (SRS) on Outcomes for Patients with Brain Metastases from Non-Small Cell Lung Cancer (NSCLC)
  4. Boron Neutron Capture Therapy for Recurrent Meningiomas: An Evaluation of Dosimetric Parameters and Clinical Outcomes
  5. BCOR–CCNB3 fusion–positive sarcoma: A distinct entity among round-cell sarcomas
  6. Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
  7. BCOR–CCNB3 fusion–positive sarcoma: Clinical insights
  8. NCCN Clinical Practice Guidelines In Oncology - Bone Cancer
  9. Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified, phase II trial - ScienceDirect

Original Source(s)

BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

  • by Naoki Oike, Reiko Imai, Akira Ogose, Takashi Ariizumi, Yudai Murayama, Tomohiro Miyazaki, Kazunaga Kimura, Hajime Umezu, Hiroyuki Kawashima

  • June 10, 2026

Related Content

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib

POC1A promotes malignant phenotypes in non-triple-negative breast cancer cell models with EMT- and Wnt/β-catenin-related alterations